Grant, Call number PAR-25-352
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
National Institutes of Health
- , Add deadline: choose a calendar
- United States
- Institution applies
- Psychiatry, Neuropharmacology and
About
This U01 supports cooperative research on drugs, neurostimulation approaches and tools to measure target engagement in mental illness or substance use disorders. The program spans discovery, preclinical development and proof-of-concept testing.
Topics
- National Cooperative Drug/Device Discovery/Development Groups, search World Wide
- NCDDG, search World Wide
- drugs, search World Wide
- neurostimulation, search World Wide
- target engagement, search World Wide
- mental illness, search World Wide
- substance use disorders, search World Wide
- Discovery, search World Wide
- preclinical development, search World Wide
- proof-of-concept testing, search World Wide
Eligibility
Covers: U01 cooperative agreement for discovery, preclinical work and proof-of-concept testing.
The lead applicant must be an eligible US organization.
Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. The lead applicant must be an eligible US organization.
Source: simpler.grants.gov